PASITHEA THERAPEUTICS CORP. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
PASITHEA THERAPEUTICS CORP. (KTTA) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 15.36 million shares for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2023-08-11
- PASITHEA THERAPEUTICS CORP. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2023-03-31 was 15.36M shares, a 21.87% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2022-03-31 was 12.60M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 1 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month |
|---|---|---|---|
| 2023-06-30 | 15.36M shares 10-Q · filed 2023-08-11 | ||
| 2023-03-31 | 15.36M shares 10-Q · filed 2023-05-12 | ||
| 2022-06-30 | 12.60M shares 10-Q · filed 2023-08-11 | ||
| 2022-06-21 | 1.00M shares 10-K · filed 2023-03-30 | ||
| 2022-03-31 | 12.60M shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |